value

The Detroit automaker said Wednesday in a regulatory filing that it will cut the value of its equity stake in the ventures by $2.6 billion to $2.9 billion when results are reported early next year. In addition, GM will take $2.7 billion worth of restructuring charges, most during the fourth quarter.

Specialty drugs are adding to employer health care bills. MiBiz senior writer, Mark Sanchez, asks if this is increasing costs or creating high value?